Literature DB >> 17380404

Review: Clostridium difficile-associated disorders/diarrhea and Clostridium difficile colitis: the emergence of a more virulent era.

Perry Hookman1, Jamie S Barkin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17380404     DOI： 10.1007/s10620-006-9450-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  36 in total

1.  Cytotoxicity assay in antibiotic-associated colitis.

Authors:  T W Chang; M Lauermann; J G Bartlett
Journal:  J Infect Dis       Date:  1979-11       Impact factor: 5.226

2.  Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec.

Authors:  Jacques Pépin; Nathalie Saheb; Marie-Andrée Coulombe; Marie-Eve Alary; Marie-Pier Corriveau; Simon Authier; Michel Leblanc; Geneviève Rivard; Mathieu Bettez; Valérie Primeau; Martin Nguyen; Claude-Emilie Jacob; Luc Lanthier
Journal:  Clin Infect Dis       Date:  2005-09-20       Impact factor: 9.079

3.  Partial purification and characterization of a cytotoxin from Clostridium difficile.

Authors:  N S Taylor; J G Bartlett
Journal:  Rev Infect Dis       Date:  1979 Mar-Apr

4.  A hospital outbreak of Clostridium difficile disease associated with isolates carrying binary toxin genes.

Authors:  M Catherine McEllistrem; Robert J Carman; Dale N Gerding; C W Genheimer; L Zheng
Journal:  Clin Infect Dis       Date:  2004-12-15       Impact factor: 9.079

5.  Characterization of the enzymatic component of the ADP-ribosyltransferase toxin CDTa from Clostridium difficile.

Authors:  I Gülke; G Pfeifer; J Liese; M Fritz; F Hofmann; K Aktories; H Barth
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

6.  Comparative analysis of Clostridium difficile clinical isolates belonging to different genetic lineages and time periods.

Authors:  Patrizia Spigaglia; Paola Mastrantonio
Journal:  J Med Microbiol       Date:  2004-11       Impact factor: 2.472

Review 7.  Clostridium difficile.

Authors:  L Kyne; R J Farrell; C P Kelly
Journal:  Gastroenterol Clin North Am       Date:  2001-09       Impact factor: 3.806

8.  Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.

Authors:  Jacques Pépin; Louis Valiquette; Marie-Eve Alary; Philippe Villemure; Annick Pelletier; Karine Forget; Karine Pépin; Daniel Chouinard
Journal:  CMAJ       Date:  2004-08-31       Impact factor: 8.262

9.  Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates.

Authors:  Patrizia Spigaglia; Paola Mastrantonio
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

10.  Colitis induced by Clostridium difficile.

Authors:  J G Bartlett; T Chang; N S Taylor; A B Onderdonk
Journal:  Rev Infect Dis       Date:  1979 Mar-Apr
View more
  5 in total

1.  CAGS Clinical Practice Committee report: the science of Clostridium difficile and surgery.

Authors:  Shahzeer Karmali; Michael Laffin; Christopher de Gara
Journal:  Can J Surg       Date:  2013-12       Impact factor: 2.089

Review 2.  Focus on acute diarrhoeal disease.

Authors:  Fabio Baldi; Maria Antonia Bianco; Gerardo Nardone; Alberto Pilotto; Emanuela Zamparo
Journal:  World J Gastroenterol       Date:  2009-07-21       Impact factor: 5.742

Review 3.  Clostridium difficile associated infection, diarrhea and colitis.

Authors:  Perry Hookman; Jamie S Barkin
Journal:  World J Gastroenterol       Date:  2009-04-07       Impact factor: 5.742

4.  Tolevamer, an anionic polymer, neutralizes toxins produced by the BI/027 strains of Clostridium difficile.

Authors:  Paul L Hinkson; Carol Dinardo; Daniel DeCiero; Jeffrey D Klinger; Robert H Barker
Journal:  Antimicrob Agents Chemother       Date:  2008-04-07       Impact factor: 5.191

5.  The combined repetitive oligopeptides of clostridium difficile toxin A counteract premature cleavage of the glucosyl-transferase domain by stabilizing protein conformation.

Authors:  Alexandra Olling; Corinna Hüls; Sebastian Goy; Mirco Müller; Simon Krooss; Isa Rudolf; Helma Tatge; Ralf Gerhard
Journal:  Toxins (Basel)       Date:  2014-07-22       Impact factor: 4.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.